Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05443906 · ClinicalTrials.gov registry record · NA
Home Exercise for Individuals with Neurodegenerative Disease
A NA study of Neurodegenerative Diseases and Cerebellar Ataxia, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05443906: Recruiting NA study of Neurodegenerative Diseases and Cerebellar Ataxia, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT05443906 is a NA study of Neurodegenerative Diseases and Cerebellar Ataxia that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 30 participants, below the 168,532-participant average among 12 other Neurodegenerative Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05443906, a NA study of Neurodegenerative Diseases and Cerebellar Ataxia, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
Primary Outcome
Patient reported outcome
Conditions Studied
Interventions
- BEHAVIORAL Home exercise
Study Locations (1)
Maryland
- Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
What NCT05443906 shows while recruiting
NCT05443906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 168,532-participant average among 12 other Neurodegenerative Diseases trials with a reported enrollment target (100% lower).
The record links to 8 conditions, with Neurodegenerative Diseases appearing as the primary indexed condition, and to 1 intervention - of which Home exercise is the first listed.
NCT05443906 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05443906 about?
NCT05443906 is a clinical study titled "Home Exercise for Individuals with Neurodegenerative Disease". The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
What is the current status of trial NCT05443906?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-13. Estimated completion is 2027-07-30.
What conditions does trial NCT05443906 study?
This clinical trial studies the following conditions: Neurodegenerative Diseases, Cerebellar Ataxia, Ataxia, Leukodystrophy, LBSL.
What interventions are being tested in trial NCT05443906?
The interventions under investigation include: Home exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05443906?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05443906 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodegenerative Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05443906's enrollment target sits among peer trials
30 13th of 12 the lowest of 12 other Neurodegenerative Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurodegenerative Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurologic Stem Cell Treatment Study
RECRUITING · NA
-
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
RECRUITING · NA
-
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
ACTIVE NOT RECRUITING · NA
-
Assessing a Novel Virtual Environment That Assists With Activities of Daily Living
COMPLETED · NA
-
Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
COMPLETED · NA
-
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI